Today’s AI-powered talent marketplaces and job platforms not only connect job candidates and employers but can serve as the technical backbone and “digital front door” for an organization’s recruitment initiatives.
Northwell Health's staff program has saved the system $200 million and brought in thousands of employees in the last 10 years. The CEO of FlexStaff credits four aspects of the program for its success.
Workforce technology enables end-to-end order and staff pool management, fulfillment, compliance, invoicing and reporting to allow for the management of all flexible labor on one unified platform.
Progressive healthcare providers are increasingly using PGx to help create more informed and personalized treatment plans that improve medication management and patient outcomes.
Use of pharmacogenomic testing enables physicians to ensure that the safest, most effective medications are prescribed to every patient, reducing trial and error prescribing and improving treatment outcomes.
This article explores Inova Health’s initiatives to make pharmacogenomics the standard of care, and how they integrated genomic decision support within the health system’s EHR.
When the CMS’ new 14-day rule took effect Jan. 1, conditions for laboratories doing outpatient reference testing might have changed for the better. But for labs navigating the new billing regulations, some forecasters are predicting confused seas ahead.
Anatomic pathology systems providers need to be creative in helping their clients get the solutions they need to be scalable, competitive, and profitable.
Pediatric pharmacogenomics is beginning to be used in pediatric hospitals to detect impaired or heightened drug responses, and may be coming to community pharmacies.
CVS Health's plans to create "community-based health hubs" following its acquisition of Aetna has the potential to push more basic lab services away from traditional lab providers
CMS issued clinical lab fee schedule final prices slated to go into effect in 2018, even though a significant portion of the lab industry had urged the government payor to delay doing so.
A large-scale study strengthens the case that preemptive genotyping can provide actionable information to help clinicians make better treatment decisions
Lagging in precision medicine is an information system infrastructure that will provide the capability to store, access, and flag pharmacogenomics test results over our lifetimes, anywhere, any time.
Under the Protecting Access to Medicare Act of 2014, Medicare rates for laboratory tests will be recalculated to reflect market-based pricing. But are labs going to get a market-based price, or is CMS gaming the system to ensure there will be a cut to the fee schedule?
For hospital and health system labs, PAMA will substantially reduce Medicare payments for the highest volume diagnostic laboratory tests, a move that will have a significant impact on laboratory margins.
With outreach lab services becoming more and more critical to healthcare delivery models as testing availability increases, and with impending Medicare payment reform for laboratories in 2018, this is an optimal time to evaluate your RCM system's ability to help you sustain the challenges and opportunities ahead.
To optimize the implementation and potential benefits of a pharmacogenomic testing program, consideration should be given to choosing the right test menu, educating healthcare providers and patients, and seamlessly integrating pharmacogenomic data and clinical decision support systems into existing processes and systems.
Telehealth is fundamentally changing how healthcare leaders handle care delivery. In the ever-changing digital age, it’s important to stay current on telehealth to provide a higher level of care to patients and work toward improved interoperability within the healthcare system.
Integrated diagnostic and genomic reporting has significant potential to inform precision-based treatment and support collaborative, patient-centered care.
Older adults are at increased risk of adverse drug events, but would medication treatments that are tailored to each person’s genetic makeup help reduce dangerous side-effects and interactions in long-term care?
New API queries Knowledge-as-a-Service platform for drug-drug-gene intelligence to improve the prescription ordering process, alert clinicians to potential adverse drug events, and suggest medication alternatives.
Sanford is expanding its genomics program — called Imagenetics — throughout the organization’s Epic electronic health records system, integrating genetics and genomic information into primary care for adults.
A leading vendor of clinical decision support and precision medicine technology is working with First Databank on a new gene-based drug-drug interaction capability.
Inova Translational Medicine Institute has selected Translational Software as the data interpretation partner for MediMap, a new pharmacogenetics test for newborns that is now being offered at Inova Women's Hospital.
Health systems, social workers and advocacy groups are using connected care platforms to collaborate, giving front-line clinicians expert help in diagnosing children's cases.
The clinical laboratory community recognizes the need to provide payors and policymakers with a clear understanding of the value of diagnostic testing.
Laboratories continue to face numerous and unrelenting challenges driven by government and regulatory forces that leave many wondering how or if to move forward.
Engaging employees in wellness programs is challenging at the best of times, but for employers in industries where the majority of workers are not in an office setting, it can be even more difficult.
Social programs that support all areas of well-being are playing a key role in inspiring employees and increasing their ability to lead healthier lives.
Efforts to align pathology and radiology are picking up steam. As payment shifts to so-called value-based care and as medical record systems may challenge successful test interpretation, many experts seek a clear integration of these two specialties.
Congress has set laboratory medicine on a new course with a law that dramatically shifts how labs will be paid, upending a decades-old system of fee-for-service payment on the clinical laboratory fee schedule.
Scheduled to be fully implemented in 2017, new legislation includes a number of key improvements and solutions to longstanding flaws in the current payment system for diagnostic tests.
